1/PS1)"Ч"( (L1/L0)"Ч"( (PF1/PF0), wherein: A1 is the current patient's blood amylase; A0 is the previous patient's blood amylase; PS1 is the current patient's average pulse; PS0 is the previous patient's average pulse; L1 is the current leukocyte count; L0 is the previous leukocyte count; PF1 is the current 'pain factor'; PF0 is the previous 'pain factor': PF is the 'pain factor', a degree of manifestation of pain syndrome appraised by points: 0 points - no rest and palpation abdominal pain; 1 point - palpation abdominal pain, no rest abdominal pain; 2 points - rest abdominal pain, increasing palpation abdominal pain; 3 point - pain syndrome accompanied by positive peritoneal symptoms. If DPI1, the conducted anti-pancreatic therapy is considered to be effective and adequate. DPI≥1 shows inactive treatment that should be corrected.;EFFECT: simplified and more accurate determination of effectiveness of the conducted anti-pancreatic therapy.;1 ex"/>
公开/公告号RU2520658C1
专利类型
公开/公告日2014-06-27
原文格式PDF
申请/专利号RU20120152206
发明设计人 TUROVETS MIKHAIL IVANOVICH;VEDENIN JURIJ IGOREVICH;ZJUBINA ELENA NIKOLAEVNA;MANDRIKOV VIKTOR VIKTOROVICH;
申请日2012-12-04
分类号G01N33/48;
国家 RU
入库时间 2022-08-21 15:38:30